exh_1068.htm


Exhibit 10.68


 



Confidential treatment has been requested for portions of this exhibit. The copy filed herewith omits the information subject to the confidentiality request. Omissions are designated as [***]. A complete version of this exhibit has been filed separately with the Securities and Exchange Commission.




 




	
AMENDMENT OF SOLICITATION/MODIFICATION OF CONTRACT

	 	
1. CONTRACT ID CODE

	
PAGE OF PAGES


	 	 	 	 	 	 	V	1	2
	
2. AMENDMENT/MODIFICATION NO

	
3. EFFECTIVE DATE

	4. REQUISITION/PURCHASE REQ. NO.	 	
5. PROJECT NO. (If applicable)


	
P00026

	 	

25-Jul-2014



	
SEE SCHEDULE

	 	 	 	 	 
	
6. ISSUED BY

	
CODE

	
W911QY

	
7. ADMINISTERED BY (If other than item 6)

	
CODE

	
SCN01A


	
W6QK ACC-APG NATICK



CONTRACTING DIVISION BLDG 1 KANSAS STREET



NATICK MA 01760-5011





	
DCMA AMERICAS (CANADA) 

275 BANK ST. 

SUITE 200 

OTTAWA, ONT. CNK2P-2L6








  

	 	 	 
	 	 	 	 	 	 	 	 	 	 
	
8. NAME AND ADDRESS OF CONTRACTOR (No., Street, County, State and Zip Code)



TEKMIRA PHARMACEUTICALS CORPORATION



	 	
9A. AMENDMENT OF SOLICITATION NO.


	8900 GLENLYON PKY SUITE 100 

BURNABY V5J 5J8

	 	
9B. DATED (SEE ITEM 11)


  


	 	X	
10A. MOD. OF CONTRACT/ORDER NO.


W9113M-10-C-0057


	 	X	10B. DATED (SEE ITEM 13)
	
CODE L8144

	 	
FACILITY CODE

	 	
14-Jul-2010


	
11. THIS ITEM ONLY APPLIES TO AMENDMENTS OF SOLICITATIONS


	o	
The above numbered solicitation is amended as set forth in Item 14. The hour and date specified for receipt of Offer

	 	
o is extended        o is not extended.


	 	
Offer must acknowledge receipt of this amendment prior to the hour and date specified in the solicitation or as amended by one of the following methods:


(a) By completing Items 8 and 15, and returning _____ copies of the amendment; (b) By acknowledging receipt of this amendment on each copy of the offer submitted; or (c) By separate letter or telegram which includes a reference to the solicitation and amendment numbers. FAILURE OF YOUR ACKNOWLEDGMENT TO BE RECEIVED AT THE PLACE DESIGNATED FOR THE RECEIPT OF OFFERS PRIOR TO THE HOUR AND DATE SPECIFIED MAY RESULT IN


REJECTION OF YOUR OFFER. If by virtue of this amendment you desire to change an offer already submitted, such change may be made by telegram or letter, provided each telegram or letter makes reference to the solicitation and this amendment, and is received prior to the opening hour and date specified.

	 
	
12. ACCOUNTING AND APPROPRIATION DATA (If required)

	 	 
	 	 	 	 	 	 	 	 	 	 
	
13. THIS ITEM APPLIES ONLY TO MODIFICATIONS OF CONTRACTS/ORDERS. 


IT MODIFIES THE CONTRACT/ORDER NO. AS DESCRIBED IN ITEM 14.


	 	
A. THIS CHANGE ORDER IS ISSUED PURSUANT TO: (Specify authority) THE CHANGES SET FORTH IN ITEM 14 ARE MADE IN THE CONTRACT ORDER NO. IN ITEM 10A.


	 	 	 	 	 	 	 	 	 	 
	 	
B. THE ABOVE NUMBERED CONTRACT/ORDER IS MODIFIED TO REFLECT THE ADMINISTRATIVE CHANGES (such as changes in paying office, appropriation date, etc.) SET FORTH IN ITEM 14, PURSUANT TO THE AUTHORITY OF FAR 43.103(B).


	X	
C. THIS SUPPLEMENTAL AGREEMENT IS ENTERED INTO PURSUANT TO AUTHORITY OF:


Mutual Agreement of Both Parties


	 	
D. OTHER (Specify type of modification and authority)


	 	 	 	 	 	 	 	 	 	 
	
E. IMPORTANT: Contractor     o is not,     x is required to sign this document and return       1        copies to the issuing office.


	
14. DESCRIPTION OF AMENDMENT/MODIFICATION (Organized by UCF section headings, including solicitation/contract subject matter where feasible.)



Modification Control Number:      soconnel142671




See attached Summary of Changes.




 


 


 


 


 


Except as provided herein, all terms and conditions ofthe document referenced in Item 9A or 10A, as heretofore changed, remains unchanged and in full force and effect.


 


 


 






	
15A. NAME AND TITLE OF SIGNER (Type or print)



Ian MacLachlan, Ph.D. Executive Vice President and Chief Technical Officer



	
16A. NAME AND TITLE OF CONTRACTING OFFICER (Type or print)



SANDRA OCONNELL



	 
	 	 	 	 	
TEL: 

	
EMAIL:  

	 
	
15B. CONTRACTOR/OFFEROR

	
15C. DATE SIGNED

	16B. UNITED STATES OF AMERICA	
16C. DATE SIGNED


	 	 	 	 	 	 	 	 	 	 
	 	
/s/ Ian MacLachlan

	 	
25-Jul-2014

	BY  /s/ Sandra O'Connell	
25-Jul-2014

	 
	 	
(Signature of person authorized to sign)

	 	 	
(Signature of Contracting Officer)

	 	 	 





 



	EXCEPTION TO SF 30 

APPROVED BY OIRM 11-84

	
30-105-04

	
STANDARD FORM 30 (Rev. 10-83)


Prescribed by GSA 


FAR (48 CFR) 53.243







 




  





  











  






W9113M-10-C-0057



(soconnell42671)


Page 2 of 2


 







SECTION SF 30 BLOCK 14 CONTINUATION PAGE


 


SUMMARY OF CHANGES







 


SECTION  SF 30 - BLOCK 14 CONTINUATION PAGE












The following have been added by full text:


P00027


A. Pursuant to mutual agreement by both parties, the purpose of this bilateral modification is to provide [***].







1. [***]: [***]







B. Tekmira Pharmaceuticals Inc., acknowledges and agrees by signature on this modification that the [***].








C.  All Other Terms and Conditions of this contract remain the same and in full force and effect.









 


 


(End of Summary of Changes)